EVLO
Evelo Biosciences Inc

1,480
Mkt Cap
$9,500.00
Volume
5,539.00
52W High
$0.0025
52W Low
$0.0001
Price
$0.0005
EVLO Fundamentals
Prev Close
$0.0005
Open
$0.0005
50D MA
$0.0005
Beta
-14.65
Avg. Volume
552.76
Loading...
Loading...
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Evelo Biosciences Inc?
What is the 52-week high for Evelo Biosciences Inc?
What is the 52-week low for Evelo Biosciences Inc?
What is Evelo Biosciences Inc stock price today?
What was Evelo Biosciences Inc stock price yesterday?
What is the 50-day moving average of Evelo Biosciences Inc?

Latest EVLO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.